Andrew Sleight
Chairman
Pharmaceutical
AB2 Bio Ltd
Switzerland
Biography
Dr. Sleight joined AB2 Bio in 2013 bringing with him over 25 years of experience in the Pharmaceutical Industry including 21 years with Roche where he was Global Therapeutic Area Head of Neuroscience. While at Roche, he also held the positions of Chairman of the Neuroscience Strategy Committee and Global Head of Business Development for Vascular and Metabolic Therapeutic Area. Dr. Sleight holds a B.Sc from the University of Bath, a Ph.D. from the University of Nottingham and a Post-Doctoral Diploma from Stanford University.
Research Interest
Vascular and Metabolic Therapeutic Area
